The National Institute on Aging (NIA), through its Aging Research federal grant program (CFDA 93.866), awarded a $3,653,891 Project Grant to Theranova LLC, a veteran-owned medical device research and development company based in San Francisco, CA. The grant funding will enable Theranova to further develop and commercialize the Entarik system, a low-cost enteral feeding system that provides real-time confirmation of feeding tube location at the bedside during insertion and continuous monitoring...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to develop a cost-effective Optical Sensor-Enabled Endotracheal Tube (OS-ETT) to reduce the risks of esophageal intubation and unintended extubation. The $1,013,000 award, effective September 1, 2024 through August 31, 2025, will support the feasibility demonstration of the OS-ETT, including optimizing the LED-photodiode array and signal processing algorithm for vocal...
The National Science Foundation awarded a $275,990 Small Business Technology Transfer Phase I Project Grant to CB Enterprises of Santa Monica, California under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The grant funds the development of an integrated biomedical platform and custom algorithm to optimize feeding protocols for preterm infants. The platform utilizes sensors and data analytics to precisely measure infant breathing patterns during feeding, providing...
This Cooperative Agreement award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $943,819 to Neocare Innovations, Inc. to develop an integrated biomedical platform and custom algorithm to optimize feeding protocols for preterm infants in neonatal intensive care units (NICUs). The project aims to create a device that uses big data on breathing patterns to quantify the synchronization of breathing and swallowing in...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant awarded $274,440 to Vine Medical Inc., a for-profit manufacturing company, to develop a proof-of-concept for a self-deploying endotracheal intubation device. The proposed soft robotics system aims to achieve over a 90% first-pass intubation success rate, which would improve patient outcomes and reduce complications during emergency airway management procedures. The device is designed to...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a modern Electrical Impedance Tomography (EIT) device for monitoring children in the Intensive Care Unit (ICU). The $299,900 award to Goodlife Inventors LLC will fund efforts to (1) generate initial designs for an advanced lightweight EIT belt and (2) assess the technical feasibility of a miniaturized, easier to use EIT core device. If...
This Project Grant award of $291,523 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to develop an AI-driven Total Parenteral Nutrition (TPN) platform for premature newborns in neonatal intensive care units (NICUs). The key goals are to create standardized TPN units for cost-effective and personalized nutrition, and validate the TPN2.0 platform against the best standard of...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program provides $550,000 to develop a remote monitoring system to reduce morbidity and mortality associated with infections among patients undergoing peritoneal dialysis (PD). The project aims to create a medical device that can enable real-time, continuous, and quantitative monitoring of numerous biomarkers relevant to PD-associated infections. This technology...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $704,672 Phase I Small Business Innovation Research (SBIR) grant under CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research) to Flowpoint Medical Inc. in Overland Park, Kansas. The grant supports the development of an implantable, self-sealing needle guide system to improve vascular access and safety for hemodialysis patients. The project aims to refine the manufacturability and...
This $256,000 National Science Foundation project grant supports the development of an automated chest tube to prevent clotting. Circulatech LLC will design and prototype a novel chest tube that proactively manages fluid flow within the catheter lumen to flush and drain the tube, reducing blood clot formation. Through a process called "dilutional coagulopathy," the tube will use sterile saline or anticoagulants to reduce thrombosis in the drainage space rather than relying on...
A NOVEL ENTERAL FEEDING SYSTEM FOR THE EARLIER AND SAFER DELIVERY OF ENTERAL NUTRITION THROUGH CONTINUOUS MONITORING OF TIP LOCATION - ABSTRACT IN THE INTENSIVE CARE UNIT (ICU), ENTERAL NUTRITION (EN) IS A CRITICAL COMPONENT OF CARE THAT PROVIDES BOTH NUTRITIONAL AND NON-NUTRITIONAL BENEFITS INCLUDING DECREASED RISK OF INFECTION, SHORTER HOSPITAL STAY AND DECREASED RISK OF MORTALITY. IT IS ESTIMATED THAT MORE THAN 1.2 MILLION FEEDING TUBES (FTS) ARE USED EACH YEAR IN THE UNITED STATES TO DELIVER EN. HOSPITAL AND CRITICAL CARE ADMITTANCE INCREASE WITH AGE RESULTING IN PATIENTS OLDER THAN 65 YEARS BEING THE LARGEST SUBPOPULATION WITHIN THE ICU TO BENEFIT FROM RAPID AND CONSISTENT EN. THE CURRENT GOLD STANDARD METHOD FOR FT PLACEMENT, BLIND BEDSIDE INSERTION, RESULTS IN FIRST ATTEMPT PLACEMENT FAILURE IN 8-60% (AVERAGE 32.3%) OF CASES. IF UNDETECTED, THESE MISPLACEMENTS CAN LEAD TO SERIOUS PATIENT HARM. AS SUCH, RADIOGRAPHIC VERIFICATION IS REQUIRED TO CONFIRM THE CORRECT FT POSITIONING. WITH THE HIGH RATE OF FAILED ATTEMPTS, THE INHERENT DELAYS ASSOCIATED WITH REPEATED X-RAYS NOT ONLY ADD TO PERSONNEL TIME AND HEALTH CARE COSTS BUT CAN LEAD TO SUBOPTIMAL OUTCOMES FOR PATIENTS WHERE EARLY EN IS CRITICAL. ONCE PLACED, UNINTENTIONAL FT DISLODGEMENT OCCURS IN AS MANY AS 33-63% OF FTS AND HAS THE POTENTIAL TO BE A SERIOUS HAZARD IF EN IS DELIVERED INTO THE PHARYNX OR LUNGS. THUS, FT POSITION MUST BE ROUTINELY VERIFIED BY CRITICAL CARE STAFF AND, IF NECESSARY, RE-INSERTED WITH PLACEMENT CONFIRMATION, ALL OF WHICH RESULTS IN INCREASED DEMAND ON NURSING TIME, INCREASED COST AND DELAYED EN. TO REDUCE THE OCCURRENCE OF MISPLACEMENT, SMART FT SYSTEMS HAVE RECENTLY BEEN DEVELOPED, BUT THE HIGH COSTS AND EXPERTISE/TRAINING REQUIRED TO USE THESE DEVICES HAVE LIMITED THEIR CLINICAL ADOPTION. FURTHER, THESE SMART SYSTEMS DO NOT MONITOR FOR FT DISLODGEMENT. THUS, THERE IS STILL AN URGENT NEED FOR A SMART FT THAT IS AN EASY-TO-USE, INEXPENSIVE, AND COMPREHENSIVE SOLUTION FOR PATIENT EN CARE. THERANOVA HAS DEVELOPED THIS SOLUTION IN THE ENTARIK SYSTEM, A LOW-COST ENTERAL FEEDING SYSTEM THAT PROVIDES REAL-TIME CONFIRMATION OF FT LOCATION AT THE BEDSIDE FOR BOTH INSERTION GUIDANCE AND DISLODGEMENT MANAGEMENT. IN OUR PREVIOUS WORK, THE ENTARIK SYSTEM (1) ACCURATELY CLASSIFIED THE AIRWAY, ESOPHAGUS AND STOMACH IN A CLINICAL STUDY (2) ACCURATELY DETECTED DISLODGEMENT OF THE FT INTO THE ESOPHAGUS FROM THE STOMACH AND (3) DEMONSTRATED RELIABLE, DURABLE PERFORMANCE IN A BENCH SIMULATION OF THE GASTRIC ENVIRONMENT. IN THIS PHASE II PROPOSAL, WE WILL VALIDATE THE SAFE AND EFFECTIVE FT PLACEMENT AND DISLODGEMENT DETECTION IN BOTH HEALTHY AND CRITICALLY ILL PATIENTS. IN SPECIFIC AIM 1, A CLINICAL STUDY IN HEALTHY PARTICIPANTS PRIOR TO AND FOLLOWING GASTRIC ACID SUPPRESSION WILL VALIDATE THE ACCURACY OF ENTARIK IN BOTH GUIDED FT PLACEMENT AND DISLODGEMENT DETECTION. IN SPECIFIC AIM 2, A RANDOMIZED, CONTROLLED STUDY WILL BE CONDUCTED TO VALIDATE THE PERFORMANCE OF THE ENTARIK SYSTEM IN AGING MEDICAL AND SURGICAL ICU PATIENTS, AS THIS REPRESENTS A LARGE POPULATION OF HIGH-RISK PATIENTS FOR FT MISPLACEMENT. THE SUCCESSFUL COMPLETION OF THE PROPOSED EFFORT WILL SUPPORT 510(K) CLEARANCE OF THE ENTARIK SYSTEM FOR GUIDING FT PLACEMENT WITHOUT THE NEED FOR X-RAY CONFIRMATION. AS A LOW-COST AND EASY-TO-USE SYSTEM, THE PERFORMANCE DATA WILL SUPPORT THAT OUR DEVICE IS AN OVERALL SUPERIOR OPTION TO CURRENT SMART FTS, DRIVING CLINICAL ADOPTION.